|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Cellix Ltd. Is Successful Grant Recipient Of FP7 Marie Curie Industry Academia Partnership And Pathways (IAPP) Grant In The Area Of Melanoma Research Co-Ordinated By University College Dublin
11/19/2009 12:59:38 PM
The European Commission recently awarded an FP7 Marie Curie Industry Academia Partnership and Pathways (IAPP) grant, termed Target-Melanoma, totalling €1,736,483 to Prof. William Gallagher’s group at University College Dublin. The grant, which will run from 2009-2013, will be distributed between the consortium members comprising academic institutions and industrial organisations including the UCD Conway Institute, University College Dublin (Co-ordinator, Ireland), Cellix Ltd. (Ireland), Institut d’Investigacio Biomedica de Bellvitge (Spain), University of Maastricht (The Netherlands), University Hospitals and Katholieke Universiteit Leuven (Belgium), Swedish Human Proteome Resource and Uppsala University (Sweden), OncoMethylome Sciences (Belgium), SlidePath (Ireland) and OncoMark Ltd. (Ireland).
|
|
|
|
|
|
|
|
|
|
|